Treatment of difficult cases of systemic-onset juvenile idiopathic arthritis with tacrolimus

European Journal of Pediatrics

Volumn 166, Issue 10, 2007, Pages 1053-1055

  Tanaka, Hiroshi ^a   Tsugawa, Koji ^a   Suzuki, Koichi ^a   Oki, Ei Shin ^a   Nonaka, Kazuhito ^b   Kimura, Shigeru ^b   Ito, Etsuro ^a  

^a HIROSAKI UNIVERSITY   (Japan)

^b AKITA RED CROSS HOSPITAL   (Japan)

Author keywords

Systemic onset juvenile idiopathic arthritis; Tacrolimus

Indexed keywords

AURANOFIN; AZATHIOPRINE; CYCLOSPORIN A; METHOTREXATE; MIZORIBINE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE; TACROLIMUS;

ANAMNESIS; ARTICLE; CASE REPORT; CHILD; COMBINATION CHEMOTHERAPY; CREATININE BLOOD LEVEL; DISEASE COURSE; DRUG BLOOD LEVEL; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FEVER; GLOMERULUS FILTRATION RATE; HUMAN; INFECTION; JUVENILE RHEUMATOID ARTHRITIS; LABORATORY TEST; MALE; PRIORITY JOURNAL; RASH; SIDE EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

ARTHRITIS, JUVENILE RHEUMATOID; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; THALIDOMIDE;

EID: 34548178205     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00431-006-0380-0     Document Type: Article

References (11)

1. Davies TH, Ning YM, Sanchez ER (2005) Differential control of glucocorticoid receptor hormone-binding function by tetratricopeptide repeat (TPR) proteins and immunosuppressive ligand FK506. Biochemistry 44:2030-2038
2. Kawai S, Yamamoto K (2006) Safety of tacrolimus, an immunosuppressive agent, in the treatment of rheumatoid arthritis in elderly patients. Rheumatology 45:441-444
3. Kimura Y, Pinho P, Walco G, Higgins G, Hummell D, Szer I, Henrickson M, Watcher S, Reiff A (2005) Etanercept treatment in patients with refractory systemic onset juvenile rheumatoid arthritis. J Rheumatol 32:935-942
4. Kondo H, Abe T, Hashimoto H, Uchida S, Irimajiri S, Hara M, Sugawara S (2004) Efficacy and safety of tacrolimus (FK506) in treatment of rheumatoid arthritis: a randomized, double blind, placebo controlled dose-finding study. J Rheumatol 31:243-251
5. Mok CC, Tong KH, To CH, Siu YP, Au TC (2005) Tacrolimus for induction therapy of diffuse proliferative lupus nephritis: an open-labeled pilot study. Kidney Int 68:813-817
6. Quartier P, Taupin P, Bourdeaut F, Lemelle I, Pillet P, Bost M, Sibilia J, Kone-Paut I, Grandon-Laloum S, LeBideau M, Bader-Meunier B, Mouy R, Debre M, Landais P, Prieur AM (2003) Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type. Arthritis Rheum 48:1093-1101
7. Segarra A, Vila J, Pou L, Majo J, Arbos A, Quiles T, Piera LL (2002) Combined therapy of tacrolimus and corticosteroids in cyclosporin-resistant or -dependent idiopathic focal segmental glomerulosclerosis: a preliminary uncontrolled study with prospective follow-up. Nephrol Dial Transplant 17:655-662
8. Suzuki K, Tsugawa K, Tanaka H (2006) Tacrolimus for the treatment of focal segmental glomerulosclerosis resistant to cyclosporine A. Pediatr Nephrol DOI 10.1007/ s00467-006-0198-z
9. Tanaka H, Tsugawa K, Nakahata T, Suzuki K, Ito E (2006) Leukocytapheresis for the treatment of refractory systemic-onset juvenile idiopathic arthritis. Clin Rheumatol DOI 10.1007/s10067-006-0256-8
10. Tsugawa K, Tanaka H, Nakahata T, Ito E (2004) Effective therapy of a child case of refractory nephrotic syndrome with tacrolimus. Tohoku J Exp Med 204:237-241
11. Yokota S, Miyamae T, Imagawa T, Iwata N, Katakura S, Mori M, Woo P, Nishimoto N, Yoshizaki K, Kishimoto T (2005) Therapeutic efficacy of humanized recombinant anti-interleukin-6 receptor antibody in children with systemic-onset juvenile idiopathic arthritis. Arthritis Rheum 52:818-825